Fanny Chasseloup1,2, Nathan Pankratz3, John Lane3, Fabio R Faucz1, Margaret F Keil1, Prashant Chittiboina4, Denise M Kay5, Tara Hussein Tayeb6,7, Constantine A Stratakis1, James L Mills8, Laura C Hernández-Ramírez1. 1. Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland. 2. Department of Endocrinology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Institut Cochin, INSERM U1016 CNRS 8104 Paris Descartes University, Paris, France. 3. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota. 4. Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland. 5. Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, New York. 6. College of Medicine, Sulaimani University, Sulaimani, Kurdistan, Iraq. 7. Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. 8. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland.
Abstract
CONTEXT: Germline loss-of-function CDKN1B gene variants cause the autosomal dominant syndrome of multiple endocrine neoplasia type 4 (MEN4). Even though pituitary neuroendocrine tumors are a well-known component of the syndrome, only 2 cases of Cushing's disease (CD) have so far been described in this setting. AIM: To screen a large cohort of CD patients for CDKN1B gene defects and to determine their functional effects. PATIENTS: We screened 211 CD patients (94.3% pediatric) by germline whole-exome sequencing (WES) only (n = 157), germline and tumor WES (n = 27), Sanger sequencing (n = 6), and/or germline copy number variant (CNV) analysis (n = 194). Sixty cases were previously unpublished. Variant segregation was investigated in the patients' families, and putative pathogenic variants were functionally characterized. RESULTS: Five variants of interest were found in 1 patient each: 1 truncating (p.Q107Rfs*12) and 4 nontruncating variants, including 3 missense changes affecting the CDKN1B protein scatter domain (p.I119T, p.E126Q, and p.D136G) and one 5' untranslated region (UTR) deletion (c.-29_-26delAGAG). No CNVs were found. All cases presented early (10.5 ± 1.3 years) and apparently sporadically. Aside from colon adenocarcinoma in 1 carrier, no additional neoplasms were detected in the probands or their families. In vitro assays demonstrated protein instability and disruption of the scatter domain of CDKN1B for all variants tested. CONCLUSIONS: Five patients with CD and germline CDKN1B variants of uncertain significance (n = 2) or pathogenic/likely pathogenic (n = 3) were identified, accounting for 2.6% of the patients screened. Our finding that germline CDKN1B loss-of-function may present as apparently sporadic, isolated pediatric CD has important implications for clinical screening and genetic counselling. Published by Oxford University Press on behalf of the Endocrine Society 2020.
CONTEXT: Germline loss-of-function CDKN1B gene variants cause the autosomal dominant syndrome of multiple endocrine neoplasia type 4 (MEN4). Even though pituitary neuroendocrine tumors are a well-known component of the syndrome, only 2 cases of Cushing's disease (CD) have so far been described in this setting. AIM: To screen a large cohort of CDpatients for CDKN1B gene defects and to determine their functional effects. PATIENTS: We screened 211 CDpatients (94.3% pediatric) by germline whole-exome sequencing (WES) only (n = 157), germline and tumor WES (n = 27), Sanger sequencing (n = 6), and/or germline copy number variant (CNV) analysis (n = 194). Sixty cases were previously unpublished. Variant segregation was investigated in the patients' families, and putative pathogenic variants were functionally characterized. RESULTS: Five variants of interest were found in 1 patient each: 1 truncating (p.Q107Rfs*12) and 4 nontruncating variants, including 3 missense changes affecting the CDKN1B protein scatter domain (p.I119T, p.E126Q, and p.D136G) and one 5' untranslated region (UTR) deletion (c.-29_-26delAGAG). No CNVs were found. All cases presented early (10.5 ± 1.3 years) and apparently sporadically. Aside from colon adenocarcinoma in 1 carrier, no additional neoplasms were detected in the probands or their families. In vitro assays demonstrated protein instability and disruption of the scatter domain of CDKN1B for all variants tested. CONCLUSIONS: Five patients with CD and germline CDKN1B variants of uncertain significance (n = 2) or pathogenic/likely pathogenic (n = 3) were identified, accounting for 2.6% of the patients screened. Our finding that germline CDKN1B loss-of-function may present as apparently sporadic, isolated pediatric CD has important implications for clinical screening and genetic counselling. Published by Oxford University Press on behalf of the Endocrine Society 2020.
Authors: Wei Wang; Margaret R Spitz; Hushan Yang; Charles Lu; David J Stewart; Xifeng Wu Journal: Clin Cancer Res Date: 2007-10-01 Impact factor: 12.531
Authors: Maria A Tichomirowa; Misu Lee; Anne Barlier; Adrian F Daly; Ilaria Marinoni; Marie-Lise Jaffrain-Rea; Luciana A Naves; Patrice Rodien; Vincent Rohmer; Fabio Rueda Faucz; Philippe Caron; Bruno Estour; Pierre Lecomte; Françoise Borson-Chazot; Alfred Penfornis; Maria Yaneva; Mirtha Guitelman; Emily Castermans; Catherine Verhaege; Jean-Louis Wémeau; Antoine Tabarin; Carmen Fajardo Montañana; Brigitte Delemer; Veronique Kerlan; Jean-Louis Sadoul; Christine Cortet Rudelli; Françoise Archambeaud; Sabine Zacharieva; Marily Theodoropoulou; Thierry Brue; Alain Enjalbert; Vincent Bours; Natalia S Pellegata; Albert Beckers Journal: Endocr Relat Cancer Date: 2012-05-03 Impact factor: 5.678
Authors: Cíntia M Camargo-Kosugi; Ismael D C G da Silva; Hélio Sato; Paulo D'Amora; Cristina V Carvalho; Naiara C Nogueira-de-Souza; Manoel J C B Girão; Eduardo Schor Journal: Eur J Obstet Gynecol Reprod Biol Date: 2009-06-02 Impact factor: 2.435
Authors: Márta Korbonits; Harvinder S Chahal; Gregory Kaltsas; Suzanne Jordan; Yulduz Urmanova; Zamira Khalimova; Philip E Harris; William E Farrell; Francois-Xavier Claret; Ashley B Grossman Journal: J Clin Endocrinol Metab Date: 2002-06 Impact factor: 5.958
Authors: Anubha Mahajan; Daniel Taliun; Matthias Thurner; Neil R Robertson; Jason M Torres; N William Rayner; Anthony J Payne; Valgerdur Steinthorsdottir; Robert A Scott; Niels Grarup; James P Cook; Ellen M Schmidt; Matthias Wuttke; Chloé Sarnowski; Reedik Mägi; Jana Nano; Christian Gieger; Stella Trompet; Cécile Lecoeur; Michael H Preuss; Bram Peter Prins; Xiuqing Guo; Lawrence F Bielak; Jennifer E Below; Donald W Bowden; John Campbell Chambers; Young Jin Kim; Maggie C Y Ng; Lauren E Petty; Xueling Sim; Weihua Zhang; Amanda J Bennett; Jette Bork-Jensen; Chad M Brummett; Mickaël Canouil; Kai-Uwe Ec Kardt; Krista Fischer; Sharon L R Kardia; Florian Kronenberg; Kristi Läll; Ching-Ti Liu; Adam E Locke; Jian'an Luan; Ioanna Ntalla; Vibe Nylander; Sebastian Schönherr; Claudia Schurmann; Loïc Yengo; Erwin P Bottinger; Ivan Brandslund; Cramer Christensen; George Dedoussis; Jose C Florez; Ian Ford; Oscar H Franco; Timothy M Frayling; Vilmantas Giedraitis; Sophie Hackinger; Andrew T Hattersley; Christian Herder; M Arfan Ikram; Martin Ingelsson; Marit E Jørgensen; Torben Jørgensen; Jennifer Kriebel; Johanna Kuusisto; Symen Ligthart; Cecilia M Lindgren; Allan Linneberg; Valeriya Lyssenko; Vasiliki Mamakou; Thomas Meitinger; Karen L Mohlke; Andrew D Morris; Girish Nadkarni; James S Pankow; Annette Peters; Naveed Sattar; Alena Stančáková; Konstantin Strauch; Kent D Taylor; Barbara Thorand; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Jaakko Tuomilehto; Daniel R Witte; Josée Dupuis; Patricia A Peyser; Eleftheria Zeggini; Ruth J F Loos; Philippe Froguel; Erik Ingelsson; Lars Lind; Leif Groop; Markku Laakso; Francis S Collins; J Wouter Jukema; Colin N A Palmer; Harald Grallert; Andres Metspalu; Abbas Dehghan; Anna Köttgen; Goncalo R Abecasis; James B Meigs; Jerome I Rotter; Jonathan Marchini; Oluf Pedersen; Torben Hansen; Claudia Langenberg; Nicholas J Wareham; Kari Stefansson; Anna L Gloyn; Andrew P Morris; Michael Boehnke; Mark I McCarthy Journal: Nat Genet Date: 2018-10-08 Impact factor: 38.330
Authors: Pietro Locantore; Rosa Maria Paragliola; Gianluca Cera; Roberto Novizio; Ettore Maggio; Vittoria Ramunno; Andrea Corsello; Salvatore Maria Corsello Journal: Int J Mol Sci Date: 2022-06-19 Impact factor: 6.208
Authors: Rosario Ferrigno; Valeria Hasenmajer; Silvana Caiulo; Marianna Minnetti; Paola Mazzotta; Helen L Storr; Andrea M Isidori; Ashley B Grossman; Maria Cristina De Martino; Martin O Savage Journal: Rev Endocr Metab Disord Date: 2021-01-30 Impact factor: 6.514